Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial

Disease relapse is the major causes of treatment failure after allogeneic stem cell transplantation (SCT) in patients with acute myeloid leukemia (AML). As well as demonstrating significant clinical activity in AML, azacitidine (AZA) upregulates putative tumor antigens, inducing a CD8(+) T cell resp...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Biol Blood Marrow Transplant
Главные авторы: Craddock, Charles, Jilani, Nadira, Siddique, Shamyla, Yap, Christina, Khan, Josephine, Nagra, Sandeep, Ward, Janice, Ferguson, Paul, Hazlewood, Peter, Buka, Richard, Vyas, Paresh, Goodyear, Oliver, Tholouli, Eleni, Crawley, Charles, Russell, Nigel, Byrne, Jenny, Malladi, Ram, Snowden, John, Dennis, Mike
Формат: Artigo
Язык:Inglês
Опубликовано: Carden Jennings Publishing 2016
Предметы:
Brief Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4728172/
https://ncbi.nlm.nih.gov/pubmed/26363443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.09.004
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы